Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» psoriasis
psoriasis
Ramaswamy's Dermavant Updates $124 Million IPO Filing
CP Wire
Mon, 06/10/19 - 09:53 am
Dermavant
IPOs
tapinarof
psoriasis
dermatitis
Vivek Ramaswamy
Ramaswamy's Dermavant Updates $124 Million IPO Filing
Mon, 06/10/19 - 09:46 am
Dermavant
tapinarof
psoriasis
dermatitis
IPOs
AbbVie's discounting Humira to aid Skyrizi's launch—and a price war could follow: analyst
Fierce Pharma
Mon, 05/20/19 - 11:07 pm
AbbVie
Humira
Skyrizi
drug launches
psoriasis
drug pricing
formulary
AbbVie successor to Humira in psoriasis gains FDA approval
BioCentury
Tue, 04/23/19 - 10:59 pm
AbbVie
Humira
psoriasis
Skyrizi
FDA
AbbVie gets its first approval for a drug execs believe could be worth up to $5B in annual sales
Endpoints
Wed, 03/27/19 - 10:19 am
AbbVie
Japan
psoriasis
risankizumab
Skyrizi
AbbVie's immunology blockbuster-to-be Skyrizi picks up first global approval
Fierce Pharma
Tue, 03/26/19 - 11:04 pm
AbbVie
Japan
Skyrizi
psoriasis
psoriatic arthritis
4 Blockbuster Drug Launches to Watch in 2019
Motley Fool
Sun, 03/24/19 - 08:08 pm
drug launches
AbbVie
Alexion Pharmaceuticals
Aimmune Therapeutics
Skyrizi
psoriasis
Upadacitinib
rheumatoid arthritis
Ultomiris
PNH
AR101
peanut allergy
Novartis data confirm rapid response and high efficacy of Cosentyx in psoriasis patients for first time in China
Pharmaceutical Business Review
Tue, 03/5/19 - 10:00 am
Novartis
Cosentyx
China
psoriasis
Novartis Sues Janssen Over False Advertisements for Psoriasis Drug
RAPS.org
Mon, 03/4/19 - 12:08 pm
Novartis
Janssen
JNJ
psoriasis
false advertising
Tremfya
Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Fierce Pharma
Fri, 03/1/19 - 11:56 am
JNJ
Janssen
Tremfya
psoriasis
Novartis
Cosentyx
Eli Lilly
Taltz
FDA approves J&J’s Tremfya self-injection pen for psoriasis
Drug Delivery Business News
Wed, 01/30/19 - 06:52 pm
JNJ
FDA
Tremfya
psoriasis
J&J still sees plenty of opportunity in crowded immunology markets—starting with psoriasis
Fierce Pharma
Wed, 01/9/19 - 12:56 pm
JNJ
JPMHC 2019
immunology
psoriasis
Tremfya
Microbiome Report for Week Ending 12/1/18
CP Wire
Sat, 12/8/18 - 02:42 pm
microbiome
Evelo Biosciences
Kaleido Biosciences
Vedanta Biosciences
psoriasis
atopic dermatitis
IBD
Microbiome Report for Week Ending 12/1/18
Mon, 12/10/18 - 09:06 am
Evelo Biosciences
Kaleido Biosciences
Vedanta Biosciences
psoriasis
atopic dermatitis
IBD
Bausch Health announces good Phase III results from psoriasis therapy
GoinPharma
Tue, 10/2/18 - 07:41 pm
Bausch Health
psoriasis
clinical trials
Bryhali
Bristol-Myers Squibb’s Psoriasis Drug Dazzles in Phase II Clinical Trial
BioSpace
Wed, 09/12/18 - 12:08 pm
Bristol-Myers Squibb
BMS-986165
psoriasis
clinical trials
MC2 Therapeutics' psoriasis drug succeeds in Phase 3 trial
Biopharma Dive
Wed, 08/22/18 - 05:50 pm
MC2 Therapeutics
clinical trials
psoriasis
MC2-01
Taclonex
Dermavant inks $330M deal for GSK's phase 3-ready psoriasis drug
Fierce Biotech
Thu, 07/12/18 - 06:17 pm
GSK
Dermavant
Roivant
CSO
tapinarof
psoriasis
atopic dermatitis
Skin treatment device-maker Clarify Medical raises $1m
Mass Device
Thu, 07/5/18 - 07:57 pm
Clarify Medical
devices
psoriasis
Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion
Marketwatch
Mon, 06/18/18 - 09:52 am
Valeant Pharmaceuticals
psoriasis
FDA
Duobrii
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »